Literature DB >> 1401384

Tobacco withdrawal in self-quitters.

J R Hughes1.   

Abstract

Self-reported and observer-rated signs and symptoms of nicotine withdrawal were assessed precessation and 2, 7, 14, 30, 90, and 180 days postcessation in smokers who quit on their own for 30 days. Anxiety, difficulty concentrating, hunger, irritability, restlessness, and weight gain increased, and heart rate decreased, postcessation (p less than .001). Except for hunger and weight gain, these symptoms returned to precessation levels by 30 days postcessation. Craving, depression, and alcohol or caffeine intake did not reliably increase. Postcessation depression, but not withdrawal symptoms, craving, or weight gain, predicted relapse. These results are consistent with prior studies.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1401384     DOI: 10.1037//0022-006x.60.5.689

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  98 in total

1.  Postquitting experiences and expectations of adult smokers and their association with subsequent relapse: findings from the International Tobacco Control (ITC) Four Country Survey.

Authors:  Hua-Hie Yong; Ron Borland; Jae Cooper; K Michael Cummings
Journal:  Nicotine Tob Res       Date:  2010-10       Impact factor: 4.244

2.  Evaluating the Effects of Varenicline on Craving, Withdrawal, and Affect in a Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Varenicline for Smokeless Tobacco Dependence in India.

Authors:  Sonali Jhanjee; Raka Jain; Veena Jain; Tina Gupta; Swati Mittal; Patricia Goelz; Robert A Schnoll
Journal:  J Psychoactive Drugs       Date:  2015-08-28

3.  Safety and tolerability of varenicline tartrate (Champix(®)/Chantix(®)) for smoking cessation in HIV-infected subjects: a pilot open-label study.

Authors:  Qu Cui; Linda Robinson; Dawn Elston; Fiona Smaill; Jeffrey Cohen; Corinna Quan; Nancy McFarland; Lehana Thabane; Andrew McIvor; Johannes Zeidler; Marek Smieja
Journal:  AIDS Patient Care STDS       Date:  2011-10-18       Impact factor: 5.078

4.  The early time course of smoking withdrawal effects.

Authors:  Peter S Hendricks; Joseph W Ditre; David J Drobes; Thomas H Brandon
Journal:  Psychopharmacology (Berl)       Date:  2006-06-03       Impact factor: 4.530

Review 5.  Distress tolerance and early smoking lapse.

Authors:  Richard A Brown; C W Lejuez; Christopher W Kahler; David R Strong; Michael J Zvolensky
Journal:  Clin Psychol Rev       Date:  2005-09

6.  The airway sensory impact of nicotine contributes to the conditioned reinforcing effects of individual puffs from cigarettes.

Authors:  Nasir H Naqvi; Antoine Bechara
Journal:  Pharmacol Biochem Behav       Date:  2005-08       Impact factor: 3.533

7.  Aripiprazole therapy for nicotine dependence.

Authors:  Sriram Ramaswamy; Subhash C Bhatia
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2006

8.  Delay discounting predicts cigarette smoking in a laboratory model of abstinence reinforcement.

Authors:  Jesse Dallery; Bethany R Raiff
Journal:  Psychopharmacology (Berl)       Date:  2007-01-05       Impact factor: 4.530

9.  Effectiveness of nicotine patch and nicotine gum as individual versus combined treatments for tobacco withdrawal symptoms.

Authors:  K O Fagerström; N G Schneider; E Lunell
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 10.  Chronic stress, drug use, and vulnerability to addiction.

Authors:  Rajita Sinha
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.